{
  "id": 1695,
  "text": "21 4-year 0S: 83.87 4-year DFS: 80</td></tr><tr><td>Duenas-Gonzalez et al.1435,1490-1492</td><td>2012</td><td>259</td><td>Cisplatin/gemcitabine</td><td>95.8</td><td>4-year DFS: 79.56 3-year 0S: 78 3-year PFS: 74.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 21 4-year 0S: 83.87 4-year DFS: 80</td></tr><tr><td>Duenas-Gonzalez et al.1435,1490-1492</td><td>2012</td><td>259</td><td>Cisplatin/gemcitabine</td><td>95.8</td><td>4-year DFS: 79.56 3-year 0S: 78 3-year PFS: 74.\n\n<question>: ",
  "ChatGPT_response_0": "根据研究结果显示，使用顺铂/吉西他滨作为治疗方案可以显著提高患者的生存率和疾病自由生存率。这种治疗方案的优势包括其在提高患者生存率和延长疾病自由生存时间方面表现突出。顺铂是一种常用的抗肿瘤药物，能够通过影响细胞的DNA复制和修复来抑制癌细胞生长。而吉西他滨则可以干扰癌细胞的DNA合成，从而抑制肿瘤生长和扩散。综合使用这两种药物可以相互增强疗效，提高治疗成功的机会，对于某些癌症类型的患者具有重要意义。当然，具体的治疗方案需要根据患者的具体情况和医生的建议来确定，以确保患者能够获得最佳的治疗效果。",
  "query": "在这项研究中，治疗方案是顺铂/吉西他滨，根据研究结果来看，患者的生存率和疾病自由生存率都有明显提高。您认为这种治疗方案的优势是什么？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在这项研究中，治疗方案是顺铂/吉西他滨，根据研究结果来看，患者的生存率和疾病自由生存率都有明显提高。您认为这种治疗方案的优势是什么？\n\n<reference text>: 21 4-year 0S: 83.87 4-year DFS: 80</td></tr><tr><td>Duenas-Gonzalez et al.1435,1490-1492</td><td>2012</td><td>259</td><td>Cisplatin/gemcitabine</td><td>95.8</td><td>4-year DFS: 79.56 3-year 0S: 78 3-year PFS: 74.\n\n<reply>: ",
  "response": "根据研究结果显示，使用顺铂/吉西他滨作为治疗方案可以显著提高患者的生存率和疾病自由生存率。这种治疗方案的优势包括其在提高患者生存率和延长疾病自由生存时间方面表现突出。顺铂是一种常用的抗肿瘤药物，能够通过影响细胞的DNA复制和修复来抑制癌细胞生长。而吉西他滨则可以干扰癌细胞的DNA合成，从而抑制肿瘤生长和扩散。综合使用这两种药物可以相互增强疗效，提高治疗成功的机会，对于某些癌症类型的患者具有重要意义。当然，具体的治疗方案需要根据患者的具体情况和医生的建议来确定，以确保患者能够获得最佳的治疗效果。"
}